SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare ...
T hinking of splashing out on a holiday this year? You deserve it. Browse our curated list of must-visit hotels and ...
Coya Therapeutics (COYA) provided a status update of its investigational regulatory T cell-derived exosome platform intended for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results